|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.49 USD | +1.75% |
|
-6.26% | -16.30% |
| Mar. 11 | Guardant Health, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 01:00 PM | |
| Mar. 11 | Braidwell, Karnal and Kreiter's AI healthcare fund, surged 28% last year | RE |
Company Valuation: Guardant Health, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 10,168 | 2,786 | 3,283 | 3,775 | 13,160 | 11,214 | - | - |
| Change | - | -72.6% | 17.84% | 14.96% | 248.64% | -14.79% | - | - |
| Enterprise Value (EV) 1 | 10,370 | 2,912 | 3,255 | 4,077 | 13,462 | 11,625 | 11,723 | 11,545 |
| Change | - | -71.91% | 11.75% | 25.27% | 230.18% | -13.65% | 0.84% | -1.52% |
| P/E ratio | -25x | -4.24x | -6.32x | -8.58x | -30.8x | -29x | -40.4x | -178x |
| PBR | 15.8x | 46.4x | 20.7x | -27.1x | -134x | -32.8x | -72.8x | 86.3x |
| PEG | - | -0.1x | 0.2x | 0.5x | 4.57x | 2.6x | 1.4x | 2.3x |
| Capitalization / Revenue | 27.2x | 6.2x | 5.82x | 5.11x | 13.4x | 8.82x | 6.86x | 5.38x |
| EV / Revenue | 27.8x | 6.48x | 5.77x | 5.52x | 13.7x | 9.14x | 7.17x | 5.54x |
| EV / EBITDA | -26.7x | -5.84x | -7.46x | -10.2x | -61x | -69x | -826x | 58.5x |
| EV / EBIT | -25.2x | -5.35x | -5.76x | -9.19x | -30.8x | -30.3x | -43.7x | -275x |
| EV / FCF | -36.5x | -7.53x | -9.42x | -14.8x | -57.8x | -49.3x | -91.9x | 105x |
| FCF Yield | -2.74% | -13.3% | -10.6% | -6.74% | -1.73% | -2.03% | -1.09% | 0.95% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -4 | -6.41 | -4.28 | -3.56 | -3.32 | -2.947 | -2.116 | -0.4807 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 373.7 | 449.5 | 563.9 | 739 | 982 | 1,272 | 1,636 | 2,083 |
| EBITDA 1 | -388.7 | -498.9 | -436.3 | -399.5 | -220.8 | -168.4 | -14.19 | 197.3 |
| EBIT 1 | -411 | -544.4 | -564.7 | -443.6 | -437.2 | -383.1 | -268.3 | -41.98 |
| Net income 1 | -405.7 | -654.6 | -479.4 | -436.4 | -416.3 | -379.8 | -266.1 | -51.83 |
| Net Debt 1 | 202.1 | 126.2 | -28.67 | 302.6 | 302.4 | 411.1 | 509.2 | 330.9 |
| Reference price 2 | 100.02 | 27.20 | 27.05 | 30.55 | 102.14 | 85.49 | 85.49 | 85.49 |
| Nbr of stocks (in thousands) | 101,656 | 102,436 | 121,380 | 123,555 | 128,839 | 131,170 | - | - |
| Announcement Date | 2/23/22 | 2/23/23 | 2/22/24 | 2/20/25 | 2/19/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -29.01x | 9.14x | -69.02x | -.--% | 11.21B | |
| 24.65x | 2.66x | 10.69x | 0.97% | 12.84B | |
| 24.52x | 8.45x | 19.43x | 2.28% | 5.98B | |
| 22.19x | 3.43x | 9.78x | - | 5.14B | |
| 174.13x | 4.5x | 27.08x | -.--% | 5.13B | |
| 19.22x | 3.32x | 10.11x | 1.92% | 3.95B | |
| 17.25x | - | - | 3.39% | 2.89B | |
| -19.39x | 3.13x | -20.56x | -.--% | 2.4B | |
| Average | 29.19x | 4.95x | -1.78x | 1.22% | 6.19B | |
| Weighted average by Cap. | 24.71x | 5.33x | -7.31x | 0.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- GH Stock
- Valuation Guardant Health, Inc.
Select your edition
All financial news and data tailored to specific country editions
